Gail Cawkwell
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Gail Cawkwell
Aclaris Therapeutics, Inc. reported in an 8-K filed February 5, 2024 that Gail Cawkwell was terminated as Chief Medical Officer, effective January 31, 2024. The proxy statement of Aclaris Therapeutics, Inc. reports total compensation of $2,403,312 for Gail Cawkwell in fiscal 2023, including a base salary of $490,000. Disclosed compensation is on record for 2 fiscal years.
“On January 31, 2024, Aclaris Therapeutics, Inc. (the "Company") terminated the employment of Gail Cawkwell, M.D., PhD., the Company's Chief Medical Officer, without cause, effective immediately.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Aclaris Therapeutics, Inc. (ACRS)
Source not stated
Start not stated–2024-01-31
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Aclaris Therapeutics, Inc. (ACRS) | Former Chief Medical Officer | $490,000 | $2,403,312 |
| 2022 | Aclaris Therapeutics, Inc. (ACRS) | Former Chief Medical Officer | $247,273 | $3,299,008 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.